Global Pork Tapeworm Infection Treatment Market Expected to Exceed US$ 25.17 Billion by 2033, with Albendazole Drugs Projected as Leading Products – FMI Report
According to Future Market Insights, the global pork tapeworm infection treatment market is expected to grow at a CAGR of 8% between 2023 and 2033, reaching US$ 25.17 Billion by 2033. It is expected that the market will further grow as the number of test kits and devices continues to increase. It is expected that the market for the treatment of pork tapeworm infection will undergo significant growth during the forecast period.
Due to an increase in pork tapeworm infections and an increasing awareness about the disease and its treatment, the market has grown substantially. Further, the emergence of new therapies and drugs for porcine tapeworm infections is expected to drive market growth. In addition, pork tapeworm infection is predicted to cause an additional surge in zoonotic diseases, driving demand for treatments that are effective in treating this condition. In addition to initiatives taken by governments, there is also expected to be a positive effect on market growth during the forecast period.
Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-16400
Infection with pork tapeworm can be treated with vaccines. Infections can be prevented or reduced in severity if they are prevented from occurring in the first place. Infection with pork tapeworm can be treated with anti-parasitic drugs. The infection of pork tapeworms can be treated naturally using remedies. A more targeted type of treatment may be developed in the future to treat pork tapeworm infections in a more practical manner. The future may also see further research that identifies more effective techniques for treating the disease and preventing it from occurring. There is a possibility that research on the genetic structure of the tapeworm might help to create drugs designed specifically to target the parasite and reduce the risk of causing adverse effects on the host, which could help to prevent the spread of the parasite. It may also be possible to reduce the spread of the disease if an improved diagnostic test is developed to detect the infection sooner rather than later.
Key Takeaways from the Market Study:
- The global market size for pork tapeworm infection treatment is estimated to reach US$ 11.66 billion by 2023.
- According to the forecast, the albendazole drug market is expected to grow by 6.2% CAGR between 2023 and 2033.
- The hospital pharmacies for pork tapeworm infection treatment market accounted for 28% of the total market value by the end of 2023.
- Pork tapeworm infection treatment in North America expanded with a market share of 19% in 2022.
- The CT scan market is expected to account for 22% of the total market value over the next few years.
“Progress in diagnostics and the development of advanced testing kits at home will further boost the pork tapeworm infection treatment market.” comments a Future Market Insights analyst.
Connect With Our Analyst To Address Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-16400
Competitive Landscape:
Markets may see many companies expand their product lines, acquire other companies, or merge their companies together in the near future due to the fact that many companies are expected to focus on the development of innovative diagnostic techniques.
- Mzansi’s pig veterinarians participated in the recent International Pig Vet Society Congress (IPVS) 2022 held in Rio De Janeiro, Brazil. Eight key veterinarians from Afrivet, the leading animal health company in South Africa, attended the five-day event. Dr. Caryn Shacklock presented Afrivet’s research on neurocysticercosis (NCC) at the event, one of the highlights. An NCC pilot vaccination study was conducted for a year in the Keiskammahoek region in the Eastern Cape. This presentation was included in the Food Safety and Parasites Session.
Key Companies Profiled:
- Winchester Hospital
- Merck & Company Inc.
- Medtronic
- Teva Pharmaceuticals Ltd.
- Eli Lilly and Company
- Sanofi S.A.
- Bayer AG
- Bristol-Myers Squibb
- Abbott
- Recordati Rare Diseases Inc.
Get Ahead With Detailed Market Intelligence: Purchase Now And Gain Access To Segment-Specific Information! https://www.futuremarketinsights.com/checkout/16400
Key Segments Profiled in the Pork Tapeworm Infection Treatment Market Industry Survey:
By Drug Type:
- Praziquantel
- Albendazole
- Nitazoxanide
- Others
By Treatment:
- CT Scan
- MRI
- Ultrasound
- X-Ray
By End User:
- Hospitals & Laboratories
- Specialty Clinics
- Ambulatory Surgical Centres
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Editor Details
-
Company:
- MARKITWIRED
- Website: